Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Inventory (2021 - 2025)

Goldenwell Biotech filings provide 5 years of Inventory readings, the most recent being $174788.0 for Q3 2025.

  • On a quarterly basis, Inventory changed 0.06% to $174788.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $174788.0, a 0.06% change, with the full-year FY2024 number at $174788.0, changed 0.04% from a year prior.
  • Inventory hit $174788.0 in Q3 2025 for Goldenwell Biotech, roughly flat from $174788.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $205725.0 in Q2 2021 to a low of $103125.0 in Q1 2021.
  • Median Inventory over the past 5 years was $175013.0 (2023), compared with a mean of $177842.1.
  • The widest YoY moves for Inventory: up 92.47% in 2022, down 12.18% in 2022.
  • Goldenwell Biotech's Inventory stood at $198671.0 in 2021, then decreased by 11.38% to $176058.0 in 2022, then fell by 0.68% to $174863.0 in 2023, then decreased by 0.04% to $174788.0 in 2024, then changed by 0.0% to $174788.0 in 2025.
  • The last three reported values for Inventory were $174788.0 (Q3 2025), $174788.0 (Q2 2025), and $174788.0 (Q1 2025) per Business Quant data.